Status:
COMPLETED
Maternal Oxygen Administration for Fetal Distress II
Lead Sponsor:
Navy General Hospital, Beijing
Conditions:
Oxygen Inhalation Therapy
Labour
Eligibility:
FEMALE
18-40 years
Phase:
NA
Brief Summary
Supplementary oxygen is routinely administered to patients, even those with adequate oxygen saturations, in the belief that it increases oxygen delivery. However, oxygen delivery depends not just on a...
Eligibility Criteria
Inclusion
- at term (\>37 weeks, \<42 weeks), singleton, cephalic presentation, spontaneous or induced labor, normal labor, category I FHR tracings, 2 to 3 cm of cervical dilation in nulliparity, 1 to 2 cm of cervical dilation in multipara, informed consent.
Exclusion
- respiratory or cardiovascular disease, diabetes mellitus or insulin-treated gestational diabetes mellitus, hypertension or preeclampsia, oligohydramnios, fetal growth restriction, placental abruption, cephalopelvic disproportion, meconium-stained amniotic fluid, tachysystole, having received O2, uterine incision (myomectomy or perforation), anemia, fever, chorioamnionitis, tobacco or alcohol use, disorders in oxygen saturations, hypotension, uncomfortable with facemask.
Key Trial Info
Start Date :
January 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2021
Estimated Enrollment :
140 Patients enrolled
Trial Details
Trial ID
NCT03764696
Start Date
January 1 2021
End Date
December 31 2021
Last Update
August 15 2023
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Obstetrics and Gynecology, PLA Strategic Support Force Characteristic Medical Center
Beijing, China
2
Department of Obstetrics and Gynecology, Seventh Medical Center, Chinese PLA General Hospital
Beijing, China
3
Department of Obstetrics and Gynecology, Sixth Medical Center, Chinese PLA General Hospital
Beijing, China